SRBCF Stock UPDATES Sirona Biochem Corp. (SRBCF) 0.1400 09/10/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sirona Biochem Corp. (SRBCF) 0.1400 $SRBCF

Sirona Biochem Announces Positive Results of PK Study for Type 2 Diabetes
Marketwire - Wed Sep 03, 3:30PM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) today announced that Wanbang Biopharmaceuticals has successfully completed another study in the pre-clinical validation of its anti-diabetic SGLT2 Inhibitor, SBM-TFC-039, for the treatment of Type 2 diabetes.

Sirona Biochem Launches Global Awareness Campaign With Cousteau Ambassadors' Video
Marketwire - Thu Aug 21, 2:00AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (FRANKFURT: ZSB) launches global awareness campaign with ambassadors' video produced by the team of Jean-Michel Cousteau and Fabien Cousteau to represent their support of the glycoprotein project.

Sirona Subsidiary, TFChem, Receives CDN$1.2 Million for Anti-Aging Project
Marketwire - Tue Aug 12, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB), (the "Company" announced that its French subsidiary, TFChem, has received confirmation for funding of CDN$1.2 million from Bpifrance (the French Public Investment Bank) and the district of Haute Normandie in the form of a no-interest loan. The funds will be used to advance the organization's anti-aging project.

Sirona Biochem Announces Successful Synthesis of Anti-Inflammatory Compound for Bloom Burton & Co. Joint Venture
Marketwire - Thu Jul 31, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB), (the "Company" announces the achievement of the first batch of compound in the joint venture with Bloom Burton & Co. ("Bloom Burton" Compounds developed within the framework of the JV will be entering development in the areas of rare inflammatory and infectious diseases.

Sirona Arranges Convertible Loans
Marketwire - Tue Jul 29, 4:48PM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB), (the "Company" announces that is has entered into convertible loan agreements with arm's length parties (the "Lenders" for the purposes of renewing current outstanding loans in the total amount of $670,000. The original loans were taken out in late 2012 and became due this quarter.

Sirona Biochem Announces Successful Completion of Two First Line Studies by Wanbang Biopharmaceuticals
Marketwire - Wed Jul 23, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM)(OTCQX: SRBCF)(FRANKFURT: ZSB) (the "Company" today announced that Wanbang Biopharmaceuticals has completed two pre-clinical efficacy studies of its SGLT2 inhibitor SBM-TFC-039. The studies independently confirm that SBM-TFC-039 increased Urinary Glucose Excretion and improved Oral Glucose Tolerance in normal SD rats. The results were consistent with those previously completed by Sirona Biochem.

Sirona Announces Shares for Services Agreement
Marketwire - Tue Jul 22, 11:27AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB), (the "Company" is pleased to announce that it has entered into a business consulting agreement (the "Agreement" with PRC Partners Ltd. of Hong Kong ("PRC" , for a six month term commencing July 15, 2014.

Sirona Biochem Corporation - CEO Letter to Shareholders
Marketwire - Mon Jul 21, 9:27AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) today provided a business update.

Sirona Announces Resignation of Neil Belenkie
Marketwire - Mon Jun 23, 4:00PM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) (the "Company" announces that Neil Belenkie has resigned as Chief Executive Officer of the Company. Neil has agreed to stay on with the company to assist in the transition until July 18, 2014. The Company thanks Mr. Belenkie for his hard work over the past 2 years and wishes him well in his future endeavors.

Sirona Biochem Announces Patent for Anti-Aging Family of Compounds
Marketwire - Tue Apr 01, 6:45AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM.V) (OTCQX: SRBCF) (FRANKFURT: ZSB) is pleased to announce that a new patent application has been deposited by its subsidiary TFChem for a second generation of glycoprotein compounds. The first target marketplace for this technology will be anti-aging cosmetics. Future applications may include consumer packaged goods and prescription pharmaceuticals.

Sirona Biochem Announces Jacques Cousteau's Son and Grandson as Brand Ambassadors
Marketwire - Thu Mar 27, 6:47AM CDT
Sirona Biochem Corp. (TSX VENTURE: SBM) (OTCQX: SRBCF) (FRANKFURT: ZSB) is pleased to announce that Jean-Michel Cousteau and Fabien Cousteau (son and grandson of Jacques Cousteau) will become Brand Ambassadors for the Company. A formal Brand Ambassador launch event has been scheduled for April 8, 2014 at TFChem in Val de Reuil, France.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viatris Declares Quarterly Dividend Amid Acquisition Buzz

Updated Category News Views 79

A Dividend Declaration with a Side of Mergers Viatris, the healthcare giant operating on a global scale, has been making some noise recently. On the surface, it's another quarterly dividend—$0.12 per share, set to hit the pockets of shareholders on December 16. But there's a lot more cooking under the hood of this announcement that ticks just about every box for a...

Continue Reading
Verismo's SynKIR™-310 Shows Promise in Phase 1 Trials

Updated Category News Views 61

KIR-CAR: A Fresh Take on Cancer Treatment So, Verismo Therapeutics is at it again with their KIR-CAR platform. They're set to present interim data at this year's ASH Annual Meeting. To all those following B-cell non-Hodgkin Lymphoma (B-NHL) treatments, pay attention. SynKIR™-310, a CD19-targeted therapy, is showing some real promise. The science behind this is like...

Continue Reading
SAFE's New Website: Engineering Excellence and Faith

Updated Category News Views 94

A Bold Digital Step for SAFE Structure Designs Now here's a move worth watching. SAFE Structure Designs, that U.S.-rooted defense contractor with its fingers in a multitude of engineering pies, just rolled out a fresh new face on the web. This isn't merely an online facelift; it's a declaration of ambition and capabilities. They're showcasing eight specialized divisions...

Continue Reading
Aeon Lands $13.8M Contract for Zeus Missile System

Updated Category News Views 165

Aeon's Big Win: SOCOM Contract for Zeus Well look at that! Aeon Industrial Inc. just snagged a pretty penny with a $13.8 million contract from the U.S. Special Operations Command (SOCOM). It's not every day a company gets to modernize the arsenal for the big leagues. This year-long deal wants Aeon at their sharpest, enhancing and testing the Zeus Missile System, known for...

Continue Reading
IM Digital Garners 2026 Klaviyo Partner Accolade

Updated Category News Views 122

Award Shows IM Digital's CRM Mastery It's not every day that a consultancy makes waves in the tech ocean, but IM Digital just scored a big one by nabbing the 2026 Klaviyo Global Partner of the Year award. When you see those shiny accolades, it's a testament to much more than just fancy buzzwords—it's about real grit and customer victories. Why It Matters in the CRM...

Continue Reading
Fluence Energy Lawsuit: Investors Face Key Deadline

Updated Category News Views 50

Fluence Energy Under Fire Fluence Energy, Inc., ain't having the best of times, folks. If you've been keeping an eye on the stock ticker NASDAQ:FLNC, you probably felt the shiver when the news of a securities fraud class action lawsuit hit the wire. This ain't about some minor slip-up. These allegations are rocking the boat hard. What's at Stake for Investors? Here's the...

Continue Reading
Navigating Builder-Ready Land: Avoid Costly Pitfalls

Updated Category News Views 18

Understanding the 'Builder-Ready' Label The term 'builder-ready' isn't as straightforward as it seems, especially when you're eye-balling land listings in rural areas. Cindy Garvey, a rural land expert, breaks down the frequent pitfalls buyers encounter when this label gets tossed around without much scrutiny. Utility Access Misconceptions Think utility access is a given?...

Continue Reading
Crocs™ Gains C2C Circularity Gold for Classic Clogs

Updated Category News Views 125

Turning Plastic into Gold Well, folks, Crocs isn't just about comfort anymore. They're wrapping their iconic Classic Clog in a shiny new accolade: Cradle to Cradle Certified® Circularity Gold Version 5.0. Imagine that—an award for making something meant to last, designed to be repurposed. They're not just slapping new paint on the same old clogs either. This...

Continue Reading
Peabody's Q3 2026: Margins Climb Despite Net Loss

Updated Category News Views 26

Tough Quarters but Promising Margins Alright, Peabody's Q3 2026 isn't the most sunshine-filled report I've laid eyes on, but it's not all shadows either. Sure, they posted a net loss of $32.8 million, better than last year's $70.1 million drain. Admit it or not, that's improvement. And yet, the real gem here is those expanding margins gleaming despite the loss-heavy...

Continue Reading
NSING's Bluetooth Milestone: A Signal for Investors

Updated Category News Views 68

The Bluetooth Bonanza: NSING Technologies' Big Win Amidst the bustling lanes of the semiconductor sector, NSING Technologies just threw down a whopper of an announcement—over 250 million Bluetooth chips shipped, all well-knitted with Ceva's technology. This isn’t just another milestone; it's a clarion call for anyone keeping an eye on the evolving landscape of...

Continue Reading

Top 5 Most Recently Viewed Articles

TTM Technologies Celebrates Awards and Leadership in Electronics

Updated Category News Views 229

TTM Technologies Recognizes Excellence at IPC CEMAC Conference SANTA ANA, Calif. — TTM Technologies, Inc. (NASDAQ: TTMI), a recognized leader in manufacturing technology products, has recently announced a remarkable achievement. During the 2025 IPC China Electronics Manufacturing Annual Conference (CEMAC), two esteemed members of the TTM team received renowned awards...

Continue Reading
OneAmerica Financial Declares Enhanced Dividend Rate for 2026

Updated Category News Views 313

OneAmerica Financial Declares Enhanced Dividend Rate for 2026 A prominent name in insurance and financial services, OneAmerica Financial, has made a significant announcement regarding its dividend allocation for policyholders of American United Life Insurance Company. This year, the company declared a notable increase in the dividend interest rate, which has risen by 10...

Continue Reading
Projected Growth in Drug-Device Combination Products Market

Updated Category News Views 152

Insights into the Drug-Device Combination Products Market The global drug-device combination products market is experiencing significant growth. Recent projections suggest that it is set to reach an impressive USD 389.7 billion by 2033, with a robust compound annual growth rate (CAGR) of 9.3% from 2024 onwards. As the healthcare landscape evolves, these combination...

Continue Reading
IPSEN's Recent Share Buy-Back Highlights and Market Impact

Updated Category News Views 168

Understanding IPSEN's Share Buy-Back Program The recent share buy-back program by IPSEN represents a strategic move in financial management. By repurchasing shares from the market, IPSEN aims to enhance shareholder value and positively impact its stock performance. Transaction Summary from Late July to Early August This segment provides an overview of IPSEN's transactions...

Continue Reading
Intensity Therapeutics Unveils Executive Stock Options to Drive Growth

Updated Category News Views 60

Stock Options Granted to Key Executives Intensity Therapeutics, Inc., a prominent biotechnology firm focused on innovative biological products, has recently made headlines by granting stock options to its key executives. This strategic move is part of the company's broader employee incentive program designed to foster loyalty and motivation among its top tier. Details of...

Continue Reading